Toll-Like Receptor 3: Involvement with Exogenous and Endogenous RNA

REFERENCES

• Lotze MT, Deisseroth A, Rubartelli A. Damage associated molecular pattern molecules. Clin Immunol 2007;124:1–4.
   PubMed Web of Science ®Google Scholar
• Gribar SC, Anand RJ, Sodhi CP, Hackam DJ. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J Leukoc Biol 2008;83:493–498.
   PubMed Web of Science ®Google Scholar
• Kumagai Y, Takeuchi O, Akira S. Pathogen recognition by innate receptors. J Infect Chemother 2008;14:86–92.
   PubMedGoogle Scholar
• Akira S, Takeda K, Kaisho T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675–680.
   PubMed Web of Science ®Google Scholar
• Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197–216.
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Janeway Jr CA. Innate immunity: The virtues of non-clonal system of recognition. Cell 1997;91:295–298.
   PubMed Web of Science ®Google Scholar
• Karikó K, Ni H, Capodici J, mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004;279:12542–12550.
   PubMed Web of Science ®Google Scholar
• Saitoh S, Miyake K. Regulatory molecules required for nucleotide-sensing Toll-like receptors. Immunol Rev 2009;227:32–43.
   PubMed Web of Science ®Google Scholar
• Beutler B, Jiang Z, Georgel P. Genetic analysis of host resistance: Toll like receptor signaling and immunity at large. Annu Rev Immunol 2006;24:353–389.
   PubMed Web of Science ®Google Scholar
• Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 2006;117:979–987.
   PubMed Web of Science ®Google Scholar
• Fukui R, Saitoh S, Matsumoto F. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing. J Exp Med 2009;206:1339–1350.
   PubMed Web of Science ®Google Scholar
• Barton GM, Kagan JC, Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006;7:49–56.
   PubMed Web of Science ®Google Scholar
• Diebold SS, Massacrier C, Akira S. Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur J Immunol 2006;36:3256–3267.
   PubMed Web of Science ®Google Scholar
• Muzio M, Bosisio D, Polentarutti N. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells. J Immunol 2000;164:5998–6004.
   PubMed Web of Science ®Google Scholar
• Rock FL, Hardiman G, Timans JC, A family of human receptors structurally related to Drosophila toll. Proc Natl Acad Sci U S A 1998;95:588–593.
   PubMed Web of Science ®Google Scholar
• Zarember KA, Godowski PJ. Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002;168:554–561.
   PubMed Web of Science ®Google Scholar
• Heinz S, Haehnel V, Karaghiosoff M. Species-specific regulation of Toll-like receptor 3 genes in men and mice. J Biol Chem 2003;278:21502–21509.
   PubMed Web of Science ®Google Scholar
• Hornung V, Rothenfusser S, Britsch S. Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002;168:4531–4537.
   PubMed Web of Science ®Google Scholar
• Lundberg AM, Drexler SK, Monaco C. Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: A phenomenon absent from murine cell systems. Blood 2007;110:3245–3252.
   PubMed Web of Science ®Google Scholar
• Orinska Z, Bulanova E, Budagian V. TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood 2005;106:978–987.
   PubMed Web of Science ®Google Scholar
• Tabiasco J, Devevre E, Rufer N. Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor. J Immunol 2006;177:8708–8713.
   PubMed Web of Science ®Google Scholar
• Wesch D, Beetz S, Oberg HH. Direct costimulatory effect of TLR3 ligand poly (I:C) on human gamma delta T lymphocytes. J Immunol 2006;176:1348–1354.
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Kikkawa S, Kohase M, Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Comm 2002;239:1364–1369.
   Google Scholar
• Matsumoto M, Funami K, Tanabe M. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 2003;171:3154–3162.
   PubMed Web of Science ®Google Scholar
• Rehli M. Of mice and men: Species variations of Toll-like receptor expression. Trends Immunol 2002;23:375–378.
   PubMed Web of Science ®Google Scholar
• Seya T, Matsumoto M. The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer. Cancer Immunol Immunother 2009;58:1175–1184.
   PubMedGoogle Scholar
• Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335–376.
   PubMed Web of Science ®Google Scholar
• Isaacs A, Klemperer HG, Hitchcock G. Studies on the mechanism of action of interferon. Virology 1961;13:191–199.
   PubMed Web of Science ®Google Scholar
• Lampson GP, Tytell AA, Field AK, Inducers of interferon and host resistance. I. Double-stranded RNA from extracts of Penicillium funiculosum. Proc Natl Acad Sci Wash 1967;58:782–789.
   PubMed Web of Science ®Google Scholar
• Field AK, Tytell AA, Lampson GP, Hilleman MR. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc Nat Acad Sci Wash 1967;58:1004–1010.
   PubMed Web of Science ®Google Scholar
• Carter WA, Pitha PM, Marshall LW. Structural requirements of the rIn:rCn complex for induction of human interferon. J Mol Biol 1972;70:567–587.
   PubMed Web of Science ®Google Scholar
• Green JJ, Alderfer JL, Tazawa I, Interferon induction and its dependence on the primary and secondary structure of poly (inosinic acid):poly(cytidylic acid). Biochemistry 1978;17:4214–4220.
   Google Scholar
• Verdijk RM, Mutis T, Esendam B. Polyriboinosinic polyribocytidylic acid (poly (I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol 1999;163:57–61.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. Antiviral signaling through pattern recognition receptors. J Biochem 2007;141:137–145.
   PubMed Web of Science ®Google Scholar
• Unterholzner L, Bowie AG. The inter play between viruses and innate immune signaling: Recent insights and therapeutic opportunities. Biochem Pharmacol 2008;75:589–602.
   PubMed Web of Science ®Google Scholar
• Ishii KJ, Koyama S, Nakagawa A, Host innate immune receptors and beyond: Making sense of microbial infections. Cell Host Microbe 2008;3:352–363.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann NY Acad Sci 2008;1143:1–20.
   PubMed Web of Science ®Google Scholar
• Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413:732–738.
   PubMed Web of Science ®Google Scholar
• Gitlin L, Barchet W, Gilfillan S. Essential role of mda-5 in type I IFN responses to polyriboinosinic: Polyribocytidylic acid and encephelamyocarditis picornavirus. PNAS 2006;103:8459–8464.
   PubMed Web of Science ®Google Scholar
• Kato H, Kato H, Sato S. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005;23:19–28.
   PubMed Web of Science ®Google Scholar
• Heinz S, Haehnel V, Karaghiosoff M. Species-specific regulation of Toll-like receptor 3 genes in men and mice. J Biol Chem 2003;278:21502–21509.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Sato S, Mori K. Cutting edge: A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002;169:6668–6672.
   PubMed Web of Science ®Google Scholar
• Honda K, Taniguchi T. IRFs: Master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006;6:644–658.
   PubMed Web of Science ®Google Scholar
• Oshiumi H, Matsumoto M, Funami K. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat Immunol 2003;4:161–167.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Sato S, Hemmi H. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003;301:640–643.
   PubMed Web of Science ®Google Scholar
• Djafarzadeh S, Vuda M, Takala J. Toll-like receptor-3-induced mitochondrial dysfunction in cultured human hepatocytes. Mitochondrion Aug 4, 2010. [Epub ahead of print]
   Google Scholar
• Sarkar SN, Peters KL, Elco CP. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 2004;11:1060–1067.
   PubMed Web of Science ®Google Scholar
• Sarkar SN, Elco CP, Peters KL, Two tyrosine residues of Toll-like receptor 3 trigger different steps of NF-kappa B activation. J Biol Chem 2007;282:3423–3427.
   PubMed Web of Science ®Google Scholar
• Sato Y, Goto Y, Narita N, Hoon DS. Cancer cells expressing Toll-like receptors and the tumor microenvironment. Cancer Microenviron 2009;1:205–214.
   Google Scholar
• Adachi O, Kawai T, Takeda K, Matsumoto M. Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 1998;9:143–150.
   PubMed Web of Science ®Google Scholar
• Wang J, Sun R, Wei H. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism. J Hepatol 2006;44:446–454.
   Google Scholar
• Gauzzi CM, Del Cornò M, Gessani S. Dissecting TLR3 signalling in dendritic cells. Immunobiology 2010;215:713–723.
   Google Scholar
• Perrot I, Deauvieau F, Massacrier C. TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA. J Immunol 2002;185:2080–2088.
   Google Scholar
• Takahashi N, Yamada T, Narita N, Fujieda S. Double-stranded RNA induces production of RANTES and IL-8 by human nasal fibroblasts. Clin Immunol 2006;118:51–58.
   PubMed Web of Science ®Google Scholar
• Mansson A, Fransson M, Adner M. TLR3 in human eosinophils: Functional effects and decreased expression during allergic rhinitis. Int Arch Allergy Immunol 2010;151:118–128.
   PubMed Web of Science ®Google Scholar
• Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002;2:773–786.
   PubMed Web of Science ®Google Scholar
• Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD. Activation of mast cells by double-stranded RNA: Evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 2004;114:174–182.
   PubMed Web of Science ®Google Scholar
• Schreiner B, Voss J, Wischhusen J. Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands. FASEB J 2006;20:118–120.
   PubMed Web of Science ®Google Scholar
• Liu Y, Kimura K, Yanai R. Cytokine, chemokine, and adhesion molecule expression mediated by MAPKs in human corneal fibroblasts exposed to poly (I:C). Invest Ophthalmol Vis Sci 2008;49:3336–3344.
   PubMed Web of Science ®Google Scholar
• Bérubé J, Bourdon C, Yao Y, Rousseau S. Distinct intracellular signaling pathways control the synthesis of IL-8 and RANTES in TLR1/TLR2, TLR3 or NOD1 activated human airway epithelial cells. Cell Signal 2009;21:448–456.
   Google Scholar
• Vercammen E, Staal J, Beyaert R. Sensing of viral infection and activation of innate immunity by Toll-like receptor 3. Clin Microbiol Rev 2008;21:13–25.
   PubMed Web of Science ®Google Scholar
• Holm CK, Petersen CC, Hvid M. TLR3 ligand polyinosinic: Polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells. J Immunol 2009;183:4422–4431.
   Google Scholar
• Nomi N, Kodama S, Suzuki M. Toll-like receptor 3 signaling induces apoptosis in human head and neck cancer via survivin associated pathway. Oncol Rep 2010;24:225–231.
   PubMed Web of Science ®Google Scholar
• McBride S, Hoebe K, Georgel P, Janssen E. Cell-associated double-stranded RNA enhances antitumor activity through the production of type I IFN. J Immunol 2006;177:6122–6128.
   PubMedGoogle Scholar
• Karikó K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by Toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005;23:165–175.
   PubMed Web of Science ®Google Scholar
• Brentano F, Schorr O, Gay RE, RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll-like receptor 3. Arthritis Rheum 2005;52:2656–2665.
   PubMed Web of Science ®Google Scholar
• Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317–1330.
   PubMed Web of Science ®Google Scholar
• Lawley W, Doherty A, Denniss S. Rapid lúpus autoantigen relocalization and reactive oxygen species accumulation following ultraviolet irradiation of human keratinocytes. Rheumatology 2000;39:253–261.
   PubMed Web of Science ®Google Scholar
• Hoffman RW, Gazitt T, Foecking MF. U1 RNA induces innate immunity signaling. Arthritis Rheum 2004;50:2891–2896.
   Google Scholar
• Cavassani KA, Ishii M, Wen W. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 2008;205:2609–2621.
   PubMed Web of Science ®Google Scholar
• Ahmad U, Ali R, Lebastchi AH. IFN-gamma primes intact human coronary arteries and cultured coronary smooth muscle cells to double-stranded RNA- and self-RNA-induced inflammatory responses by upregulating TLR3 and melanoma differentiation-associated gene 5. J Immunol 2010;185:1283–1294.
   Google Scholar
• Lee H, Jo EK, Choi SY. Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: Implication in Wallerian degeneration. Biochem Biophys Res Commun 2006;350:742–747.
   PubMed Web of Science ®Google Scholar
• Baiersdörfer M, Schwarz M, Seehafer K. Toll-like receptor 3 mediates expression of clusterin/apolipoprotein J in vascular smooth muscle cells stimulated with RNA released from necrotic cells. Exp Cell Res Aug 5, 2010. [Epud ahead of print]
   Google Scholar
• Liu AY, Torchia BS, Migeon BR, Siliciano RF. The human NTT gene: Identification of a novel 17-kb noncoding nuclear RNA expressed in activated CD4+ T cells. Genomics 1997;39:171–184.
   PubMed Web of Science ®Google Scholar
• Amarante MK, De Lucca FL, de Oliveira CE. Expression of noncoding mRNA in human blood cells activated with synthetic peptide of HIV. Blood Cells Mol Dis 2005;35:286–290.
   Google Scholar
• Karikó K, Weissman D. Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: Implication for therapeutic RNA development. Curr Opin Drug Discov Devel 2007;10:523–532.
   PubMedGoogle Scholar
• Le UM, Yanasarn N, Lohr CV. Tumor chemoimmunotherapy using gemcitabine and a synthetic dsRNA. Cancer Biol Ther 2008;7:440–447.
   PubMed Web of Science ®Google Scholar
• Salaun B, Coste I, Rissoan MC. TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 2006;176:4894–4901.
   PubMed Web of Science ®Google Scholar
• Salaun B, Lebecque S, Matikainen S. Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 2007;13:4565–4574.
   PubMed Web of Science ®Google Scholar
• Marshall-Clarke S, Downes JE, Haga IR. Polyinosinic acid is a ligand for toll-like receptor 3. J Biol Chem 2007;282:24759–24766.
   PubMed Web of Science ®Google Scholar
• Okahira S, Nishikawa F, Nishikawa S. Interferon-beta induction through toll-like receptor 3 depends on double-stranded RNA structure. DNA. Cell Biol 2005;24:614–623.
   PubMed Web of Science ®Google Scholar
• Ishii KJ, Akira S. TLR ignores methylated RNA? Immunity 2005;23:111–114.
   PubMed Web of Science ®Google Scholar
• Robinson RA, DeVita VT, evy HB. A phase I–II trial of multiple-dose polyriboinosic–polyribocytidylic acid in patients with leukemia or solid tumors. J Natl Cancer Institute 1976;57:599–602.
   PubMedGoogle Scholar
• Liu G, Friggeri A, Yang Y. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci. U S A 2009;106:15819–15824.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang X, Liu M. A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages. Immunology 2010;131:40–49.
   PubMed Web of Science ®Google Scholar
• Navabi H, Jasanib B, Reecea A. A clinical grade poly I:C-analogue (Ampligen®) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro. Vaccine 2009;27:107–115.
   PubMed Web of Science ®Google Scholar
• Jasani B, Navabi H, Adams M. Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer. Vaccine 2009;27:3401–3404.
   PubMed Web of Science ®Google Scholar
• Nallagatla SR, Toroney R, Bevilacqua PC. A brilliant disguise for self RNA: 5’-end and internal modifications of primary transcripts suppress elements of innate immunity. RNA Biol 2008;5:140–144.
   PubMed Web of Science ®Google Scholar
• Avril T, de Tayrac MC, Leberre C, Quillien V. Not all polyriboinosinic–polyribocytidylic acids (poly I:C) are equivalent for inducing maturation of dendritic cells: Implication for alpha-type-1 polarized DCs. J Immunother 2009;32:353–362.
   PubMed Web of Science ®Google Scholar
• Trumpfheller C, Caskey M, Nchinda G. The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine. Proc Natl Acad Sci U S A 2008;105:2574–2579.
   PubMed Web of Science ®Google Scholar
• McCartney S, Vermi W, Gilfillan S. Distinct complementary of MDA and TLR3 in poly (I:C)-mediated activation of mouse NK cells. J Exp Med 2009;206: 2967–2976.
   PubMed Web of Science ®Google Scholar
• Conroy H, Marshall NS, Mills KH. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours. Oncogene 2008;7:168–180.
   Google Scholar
• Kryczek I, Lange A, Mottram P. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res 2005;65:465–472.
   PubMed Web of Science ®Google Scholar
• Taura M, Fukuda R, Suico MA, Eguma A. TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis. Cancer Sci 2010;101:1610–1617.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sun R, Liu B. TLR3 activation inhibits nasopharyngeal carcinoma metastasis via downregulation. Cancer Biol Ther 2009;8:1826–1830.
   PubMed Web of Science ®Google Scholar
• Pascolo S. Vaccination with messenger RNA (mRNA). Handb Exp Pharmacol 2008;183:221–235.
   PubMedGoogle Scholar